These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1810899)

  • 21. Hydroxychloroquine alleviates persistent proteinuria in IgA nephropathy.
    Gao R; Wu W; Wen Y; Li X
    Int Urol Nephrol; 2017 Jul; 49(7):1233-1241. PubMed ID: 28349446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgA nephropathy histologically resembling focal-segmental glomerulosclerosis: a clinicopathologic study of 18 cases.
    Haas M
    Am J Kidney Dis; 1996 Sep; 28(3):365-71. PubMed ID: 8804234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Converting enzyme inhibition and progressive glomerulosclerosis in the rat.
    Beukers JJ; van der Wal A; Hoedemaeker PJ; Weening JJ
    Kidney Int; 1987 Dec; 32(6):794-800. PubMed ID: 3323601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effects of angiotensin-converting enzyme inhibitor on IgA nephropathy and the influencing factors].
    Shi X; Chen X; Liu S; Zhuang Y; Zhang Y
    Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):399-403. PubMed ID: 12137603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and pathological characteristics of Fabry disease combined with IgA nephropathy in Chinese patients
.
    Yang N; Wang X; Xu F; Zeng C; Wang J; Liu Z
    Clin Nephrol; 2017 Apr; 87 (2017)(4):188-195. PubMed ID: 28157068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgA nephropathy associated with human immuno deficiency virus infection: antiproteinuric effect of captopril.
    Górriz JL; Rovira E; Sancho A; Ferrer R; Paricio A; Pallardó LM
    Nephrol Dial Transplant; 1997 Dec; 12(12):2796-7. PubMed ID: 9430904
    [No Abstract]   [Full Text] [Related]  

  • 27. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.
    Madan A; Mijovic-Das S; Stankovic A; Teehan G; Milward AS; Khastgir A
    BMC Nephrol; 2016 Mar; 17():37. PubMed ID: 27036111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.
    Bazzi C; Rizza V; Paparella M; Casellato D; Napodano P; Olivieri G; D'Amico G
    J Nephrol; 2009; 22(3):387-96. PubMed ID: 19557716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term effects of fish oil treatment on urinary excretion of high- and low-molecular weight proteins in patients with IgA nephropathy.
    Branten AJ; Klasen IS; Wetzels JF
    Clin Nephrol; 2002 Oct; 58(4):267-74. PubMed ID: 12400841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin II local hyperreactivity in the progression of IgA nephropathy.
    Coppo R; Amore A; Gianoglio B; Cacace G; Picciotto G; Roccatello D; Peruzzi L; Piccoli G; De Filippi PG
    Am J Kidney Dis; 1993 Jun; 21(6):593-602. PubMed ID: 8503412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
    Manno C; Torres DD; Rossini M; Pesce F; Schena FP
    Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies.
    El Karoui K; Hill GS; Karras A; Moulonguet L; Caudwell V; Loupy A; Bruneval P; Jacquot C; Nochy D
    Kidney Int; 2011 Mar; 79(6):643-654. PubMed ID: 21178978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of proteinuria in primary glomerulonephritides: urinary polymers of albumin.
    Bazzi C; Petrini C; Rizza V; Arrigo G; Beltrame A; D'Amico G
    Am J Kidney Dis; 1997 Sep; 30(3):404-12. PubMed ID: 9292570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of captopril on heavy proteinuria in azotemic diabetics.
    Taguma Y; Kitamoto Y; Futaki G; Ueda H; Monma H; Ishizaki M; Takahashi H; Sekino H; Sasaki Y
    N Engl J Med; 1985 Dec; 313(26):1617-20. PubMed ID: 3906398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The influence of hypertension and antihypertensive agents on experimental IgA nephropathy (IgAN)].
    Wang L; Wang HY; Tao WY
    Zhonghua Nei Ke Za Zhi; 1991 Sep; 30(9):557-60, 594-5. PubMed ID: 1806338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary monocyte chemoattractant protein-1 excretion in children with glomerular proteinuria.
    Wasilewska A; Zoch-Zwierz W; Taranta-Janusz K; Kołodziejczyk Z
    Scand J Urol Nephrol; 2011 Feb; 45(1):52-9. PubMed ID: 21034351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of ACE genotypes and medical treatments in childhood focal glomerulosclerosis.
    Hori C; Hiraoka M; Yoshikawa N; Tsuzuki K; Yoshida Y; Yoshioka K; Fujisawa K; Tsukahara H; Ohshima Y; Mayumi M
    Nephron; 2001 Aug; 88(4):313-9. PubMed ID: 11474225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of lisinopril for mild childhood IgA nephropathy: a pilot study.
    Nakanishi K; Iijima K; Ishikura K; Hataya H; Awazu M; Sako M; Honda M; Yoshikawa N;
    Pediatr Nephrol; 2009 Apr; 24(4):845-9. PubMed ID: 18825420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulse methylprednisolone, cyclosporine, and ace inhibitor therapy decreases proteinuria in two siblings with familial focal segmental glomerulosclerosis.
    Yorgin PD; Belson A; Higgins J; Alexander SR
    Am J Kidney Dis; 2001 Jun; 37(6):E44. PubMed ID: 11382715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective randomized controlled multicenter trial on steroids plus ramipril in proteinuric IgA nephropathy.
    Manno C; Gesualdo L; D'Altri C; Rossini M; Grandaliano G; Schena FP
    J Nephrol; 2001; 14(4):248-52. PubMed ID: 11506246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.